Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT02185027
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Managed in view of surgery or an invasive procedure, emergency or not
* Managed and hospitalized for active bleeding
* Long-term therapy (in the indication atrial fibrillation or treatment of pulmonary embolism or deep vein thrombosis) by at least one antithrombotic agent from the following list: DABIGATRAN ETEXILATE MESYLATE or RIVAROXABAN or APIXABAN
Exclusion Criteria:
* Pregnant women
* Refusal to participate in the study: listed in the non-inclusion registry
* Antithrombotics indicated for the prevention of venous thromboembolism
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02185027
Study Brief:
Protocol Section:
NCT02185027